TET2 Gene

Migration, Crosslink

📖

TET2 Gene

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tet2

📖 Wiki Page

gene2244 wordssynced 2026-04-02

TET2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TET2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TET2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Tet Methylcytosine Dioxygenase 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4q24</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>93190</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>606839</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000168769</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8N8M1</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TET family (Fe(II) and 2-oxoglutarate-dependent dioxygenases)</td>
</tr>
<tr>
<td class="label">Length</td>
<td>2,236 amino acids</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">TET activators</td>
<td>Vitamin C, alpha-ketoglutarate</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>TET2 delivery to brain</td>
</tr>
<tr>
<td class="label">Anti-inflammatory</td>
<td>IL-6, TNF-alpha blockade</td>
</tr>
<tr>
<td class="label">Lifestyle interventions</td>
<td>Diet, exercise effects on epigenetics</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a

...

TET2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TET2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TET2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Tet Methylcytosine Dioxygenase 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4q24</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>93190</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>606839</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000168769</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8N8M1</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TET family (Fe(II) and 2-oxoglutarate-dependent dioxygenases)</td>
</tr>
<tr>
<td class="label">Length</td>
<td>2,236 amino acids</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">TET activators</td>
<td>Vitamin C, alpha-ketoglutarate</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>TET2 delivery to brain</td>
</tr>
<tr>
<td class="label">Anti-inflammatory</td>
<td>IL-6, TNF-alpha blockade</td>
</tr>
<tr>
<td class="label">Lifestyle interventions</td>
<td>Diet, exercise effects on epigenetics</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-d2722680" style="color:#ce93d8" title="Score: 0.51">Epigenetic Memory Erasure via TET2 Activ...</a><br><a href="/hypothesis/h-d7121bcc" style="color:#ce93d8" title="Score: 0.46">TET2-Mediated Demethylation Rejuvenation...</a><br><a href="/hypothesis/h-a90e2e89" style="color:#ce93d8" title="Score: 0.40">Temporal TET2-Mediated Hydroxymethylatio...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">310 edges</a></td>
</tr>
</table>

TET2 (Tet Methylcytosine Dioxygenase 2) is a crucial epigenetic regulator that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) in DNA[@tet2022]. This enzyme plays a fundamental role in active DNA demethylation and is essential for normal development, hematopoiesis, and cellular function. TET2 is one of the most frequently mutated genes in clonal hematopoiesis of indeterminate potential (CHIP), which has emerged as a significant risk factor for both hematologic malignancies and neurodegenerative diseases[@mcc2023].

Pathway Diagram

Mermaid diagram (expand to render)

Gene Information

Molecular Function

TET2 belongs to the TET (Ten-Eleven Translocation) family of proteins, which are Fe(II)- and 2-oxoglutarate-dependent dioxygenases. Unlike TET1, TET2 lacks the CXXC DNA-binding domain and is recruited to chromatin through interactions with other proteins, including O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) and various transcription factors[@tet2022a].

Catalytic Activity

The enzymatic reaction catalyzed by TET2 proceeds in three steps:

5mC → 5hmC: Oxidation of 5-methylcytosine to 5-hydroxymethylcytosine

5hmC → 5fC: Further oxidation to 5-formylcytosine

5fC → 5caC: Final oxidation to 5-carboxylcytosine

These oxidized cytosine derivatives can be processed through the base excision repair pathway to complete active DNA demethylation. TET2 has highest affinity for 5hmC production and is the primary enzyme responsible for 5hmC generation in many tissues.

Protein Structure

TET2 contains several key functional domains:

C-terminal catalytic domain: Contains the Fe(II) binding site and 2-oxoglutarate binding motifs
Middle region: Includes low-complexity regions involved in protein-protein interactions
N-terminal region: Proline-rich area with potential regulatory functions

Role in the Brain

Neuronal Expression and Function

TET2 is expressed in various brain cell types, including [neurons](/entities/neurons), [astrocytes](/cell-types/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation). In neurons, TET2 regulates activity-dependent gene expression by modulating DNA methylation patterns at neuronal activity-regulated genes. This function is critical for synaptic plasticity, learning, and memory formation.

5hmC in Brain Development and Aging

The distribution of 5hmC in the brain is highly dynamic during development and changes with age. In the aging brain, there is a global decrease in 5hmC levels, particularly in gene bodies of neuron-specific genes[@dna2021]. This loss of 5hmC correlates with transcriptional dysregulation and is implicated in age-related cognitive decline.

TET2 in Neuroinflammation

TET2 plays a dual role in neuroinflammation:

In microglia: TET2 regulates inflammatory gene expression; loss of TET2 function leads to hyperinflammatory responses
In neurons: TET2-mediated demethylation can suppress pro-inflammatory gene expression

The intersection of TET2 dysfunction with microglial activation represents a key mechanism linking epigenetic alterations to neuroinflammation in neurodegenerative diseases[@tet2022].

Disease Associations

Alzheimer's Disease

TET2 is increasingly recognized as relevant to Alzheimer's disease (AD) pathogenesis. Studies have identified:

Altered 5hmC patterns in AD brain tissue, particularly in regions vulnerable to neurodegeneration[@sahm2024]
TET2 expression changes in AD hippocampus and prefrontal cortex
Role in amyloid metabolism: TET2 regulates genes involved in amyloid precursor protein (APP) processing and amyloid-beta clearance
Inflammation modulation: TET2 dysfunction contributes to chronic neuroinflammation, a hallmark of AD

Parkinson's Disease

In Parkinson's disease (PD), TET2 alterations have been documented in:

Substantia nigra: Region-specific changes in 5hmC distribution
Peripheral blood cells: TET2 mutations in clonal hematopoiesis associated with increased PD risk[@epigenetic2023]
Neuroinflammation pathways: TET2-deficient microglia show enhanced pro-inflammatory responses

Frontotemporal Dementia

FTD cases show:

Altered TET2 expression in frontal and temporal cortices
5hmC pattern changes at genes involved in tau metabolism and neuronal survival
Potential overlap with myeloid malignancy pathways

Amyotrophic Lateral Sclerosis (ALS)

TET2 mutations have been detected in some ALS cases, particularly in patients with comorbid clonal hematopoiesis. The mechanism likely involves enhanced neuroinflammation through microglial dysfunction.

Clonal Hematopoiesis and Neurodegeneration

One of the most significant recent discoveries is the link between clonal hematopoiesis of indeterminate potential (CHIP) and neurodegenerative disease risk[@mcc2023]. TET2 is the most commonly mutated gene in CHIP.

Mechanistic Links

Inflammatory cytokine release: CHIP-derived microglia release elevated levels of IL-6, TNF-α, and other pro-inflammatory cytokines

Blood-brain barrier dysfunction: Inflammatory signals compromise BBB integrity

Altered microglial phagocytosis: TET2 mutations affect clearance of amyloid-beta and alpha-synuclein

Systemic inflammation: Chronic low-grade inflammation accelerates neurodegeneration

Therapeutic Implications

Small Molecule Activators

Several compounds have been identified that can enhance TET activity:

Vitamin C (ascorbic acid): Enhances TET enzymatic activity as a cofactor
Alpha-ketoglutarate derivatives: Provide substrate for TET catalysis
Natural compounds: Certain flavonoids and polyphenols show TET-activating properties

Gene Therapy Approaches

Gene delivery of functional TET2 to specific brain regions represents a potential therapeutic strategy. However, delivery challenges and off-target effects remain significant hurdles.

Anti-inflammatory Strategies

Given the strong link between TET2 dysfunction and neuroinflammation:

Microglial targeting: Modulating TET2-deficient microglial activation states
Cytokine blockade: IL-6 and TNF-α inhibitors being investigated in CHIP-associated neurodegeneration

Expression Patterns

Tissue Distribution

TET2 is widely expressed, with highest levels in:

Hematopoietic stem and progenitor cells
Brain tissue (neurons, astrocytes, microglia)
Liver and kidney

Developmental Regulation

TET2 expression peaks during embryonic development and decreases with age. The age-related decline in TET2 activity contributes to DNA methylation drift and increased inflammatory gene expression.

TET2 and the Epigenetic Clock

DNA Methylation Aging

The epigenetic clock, measured by DNA methylation patterns at specific CpG sites, is one of the most robust biomarkers of biological aging. TET2 plays a crucial role in this process:

5hmC as an epigenetic mark: Unlike 5mC, 5hmC is not passively lost during cell division, making it a stable epigenetic mark

Age-related 5hmC loss: Global decreases in 5hmC correlate with epigenetic age acceleration

TET2 and clock genes: Many genes used in epigenetic clock calculations show altered 5hmC patterns with age

Implications for Neurodegeneration

Accelerated epigenetic aging in brain regions affected by neurodegeneration
TET2 as a therapeutic target to slow or reverse epigenetic aging
Biomarker potential: 5hmC patterns may serve as indicators of brain age

TET2 in Specific Brain Regions

Hippocampus

The hippocampus, critical for learning and memory, shows:

High TET2 expression in dentate gyrus neural stem cells
Spatial memory dysfunction with TET2 deficiency
Role in adult neurogenesis through epigenetic regulation of neuronal genes

Prefrontal Cortex

In the prefrontal cortex:

TET2 regulates executive function genes
Age-related changes in 5hmC correlate with cognitive decline
TET2 dysfunction linked to working memory impairments

Substantia Nigra

The substantia nigra, affected in Parkinson's disease, shows:

Region-specific alterations in 5hmC distribution
TET2 mutations in microglia associated with increased PD risk
Role in dopaminergic neuron survival

Cerebellum

TET2 in the cerebellum:

Regulates genes involved in motor coordination
Altered 5hmC in ataxia and cerebellar degeneration

TET2 and Protein Aggregation

Amyloid Metabolism

TET2 influences amyloid precursor protein (APP) processing:

Alpha-secretase regulation: TET2-mediated demethylation promotes non-amyloidogenic processing
Amyloid-beta clearance: TET2 in microglia affects phagocytosis of amyloid plaques
BACE1 regulation: 5hmC patterns at the BACE1 gene correlate with amyloid pathology

Tau Pathology

In tauopathies:

Tau phosphorylation genes: TET2 regulates kinases and phosphatases involved in tau phosphorylation
NFT formation: 5hmC changes at tau aggregation genes
Tau spreading: TET2 in neurons affects susceptibility to tau pathology

Alpha-Synuclein

In Parkinson's disease:

SNCA regulation: TET2-mediated epigenetic changes affect alpha-synuclein expression
Lewy body formation: 5hmC patterns at genes involved in protein aggregation
Neuronal vulnerability: TET2 dysfunction increases susceptibility to alpha-synuclein toxicity

TET2 and Mitochondrial Function

Mitochondrial DNA Epigenetics

TET2 influences mitochondrial function through:

Nuclear-mitochondrial cross-talk: TET2 regulates genes involved in mitochondrial dynamics

Metabolic coupling: 2-oxoglutarate, a TET cofactor, is a key TCA cycle intermediate

mtDNA repair: TET2 may influence mitochondrial DNA repair capacity

Neurodegeneration Implications

Energy failure: Mitochondrial dysfunction is central to neurodegeneration
Oxidative stress: TET2 deficiency may exacerbate oxidative damage
Therapeutic potential: Enhancing TET2 could improve mitochondrial function

TET2 and Synaptic Function

Synaptic Plasticity

TET2 plays critical roles in synaptic plasticity:

Activity-dependent demethylation: Neuronal activity triggers TET2-mediated epigenetic changes

Learning and memory genes: 5hmC at synaptic plasticity-related genes

Immediate early gene regulation: TET2 regulates c-Fos, Arc, and other activity-dependent genes

Synaptic Dysfunction in Disease

Early synaptic loss: TET2 changes precede measurable cognitive decline
Excitotoxicity: TET2 in astrocytes affects glutamate metabolism
Synaptic pruning: TET2 in microglia regulates synaptic engulfment

Animal Models

Mouse Models

Key TET2 mouse models include:

TET2 conditional knockout: Brain-specific deletion showing cognitive deficits

TET2 floxed mice: Cre-recombinase dependent deletion in specific cell types

Humanized TET2 mice: Expressing human TET2 variants

Phenotypic Findings

Learning and memory deficits
Enhanced anxiety-like behavior
Reduced neurogenesis
Altered inflammatory responses
Accelerated aging phenotypes

Limitations and Considerations

Species differences in 5hmC patterns
Brain region-specific effects
Compensatory mechanisms in knockout models

TET2 in Specific Cell Types

Neurons

TET2 in neurons:

Regulates activity-dependent gene expression
Essential for synaptic plasticity and memory formation
Loss leads to learning and memory deficits
5hmC accumulates at neuronal activity-regulated genes

Astrocytes

In astrocytes:

TET2 regulates inflammatory gene expression
Controls astrocyte reactivity in neurodegeneration
Affects glutamate metabolism and neurotransmitter clearance

Microglia

Microglial TET2 is crucial:

TET2 mutations in microglia cause hyperinflammatory responses
Impaired phagocytosis of protein aggregates
Enhanced cytokine release (IL-6, TNF-alpha)
Central to CHIP-associated neurodegeneration

Oligodendrocytes

TET2 in oligodendrocytes:

Regulates myelination genes
Affects white matter integrity
Changes in demyelinating diseases

TET2 and Metabolic Disease

Diabetes and Neurodegeneration

TET2 links metabolic disease to neurodegeneration:

Type 2 diabetes increases AD/PD risk
TET2 in pancreatic beta cells affects insulin secretion
Metabolic dysfunction alters 5hmC patterns in brain

Obesity and Brain Aging

Adipokine effects on TET2 activity
Systemic inflammation from obesity affects brain TET2
Therapeutic implications for metabolic syndrome

TET2 Variants and Mutation Spectrum

Germline Variants

Loss-of-function mutations cause childhood AML
Missense variants in TET2 domain affect catalytic activity
Common variants may influence neurodegeneration risk

Somatic Mutations

TET2 is most frequently mutated gene in CHIP
Mutations accumulate with age
mosaicism in peripheral blood and brain

TET2 and Blood-Brain Barrier

BBB Breakdown in Neurodegeneration

TET2 affects:

Endothelial cell function
Pericyte regulation
Tight junction integrity

Therapeutic Implications

TET2 restoration could improve BBB function
Anti-inflammatory approaches reduce BBB leakiness

Clinical Trials and Interventions

Current Clinical Landscape

While no TET2-targeted trials exist for neurodegeneration:

Vitamin C trials: Assessing effects on TET activity

Epigenetic modulators: Broader HDAC inhibitors in AD trials

Anti-inflammatory approaches: Targeting CHIP-related inflammation

Therapeutic Strategies

Challenges

Brain delivery of large proteins
Specificity of small molecule activators
Off-target effects on hematopoiesis

Research Methods

5hmC Detection

Methods for studying 5hmC:

Bisulfite sequencing: Distinguishes 5mC from 5hmC

TAB-seq: Single-base resolution 5hmC mapping

OxBS-seq: Chemical oxidation of 5hmC to 5fC

Immunoassays: 5hmC-specific antibodies

TET2 Activity Assays

In vitro dioxygenase assays
Mass spectrometry for 5hmC quantification
Reporter constructs with TET-responsive elements

Single-Cell Approaches

scRNA-seq for TET2 expression
scATAC-seq for chromatin accessibility
Spatial transcriptomics of 5hmC patterns

Cross-Links

[TET1 Gene](/genes/tet1) - Related TET enzyme with distinct functions
[TET3 Gene](/genes/tet3) - Brain-enriched TET family member
[Epigenetic Regulation](/mechanisms/epigenetic-regulation) - Overview of epigenetic mechanisms
[DNA Methylation](/mechanisms/dna-methylation) - DNA methylation pathways
[Alzheimer's Disease](/diseases/alzheimers-disease) - AD disease page
[Parkinson's Disease](/diseases/parkinsons-disease) - PD disease page
[Microglia](/cell-types/microglia-neuroinflammation) - Cell type page
[DNA Methylation and Aging](/mechanisms/dna-methylation-aging)
[Epigenetic Clock](/mechanisms/epigenetic-clock)
[CHIP and Neurodegeneration](/mechanisms/chip-neurodegeneration)

Interactions and Pathways

Protein Interactions

TET2 interacts with numerous proteins:

OGT (O-linked N-acetylglucosamine transferase): Recruits TET2 to chromatin
Sin3A complex: Part of transcriptional repression machinery
IDH1/IDH2: Metabolic enzymes that produce 2-oxoglutarate, the TET cofactor
Iron metabolism proteins: Iron is an essential cofactor

Signaling Pathways

TET2 is involved in:

DNA methylation dynamics
Cellular stress responses
Inflammatory signaling (NF-κB, JAK-STAT)
Metabolic pathways (2-oxoglutarate, alpha-ketoglutarate)

Clinical Relevance

Biomarkers

TET2 mutation status in peripheral blood cells as CHIP marker
5hmC levels in circulating cell-free DNA
TET2 expression in peripheral blood mononuclear cells

Genetic Testing

TET2 sequencing is recommended for:

Patients with unexplained cytopenias
Individuals with family history of both hematologic malignancies and neurodegenerative disease
Research participants in neurodegeneration studies

References

[Cheng Y, et al., TET2 mutations in clonal hematopoiesis and Alzheimer's disease risk (2023)](https://doi.org/10.1001/jamaoncol.2023.0123)

[Zhang Q, et al., TET2 in myeloid dysfunction and neurodegeneration (2022)](https://doi.org/10.1007/s12035-022-03045-6)

[Condliffe D, et al., DNA hydroxymethylation changes in brain aging and Alzheimer's disease (2021)](https://doi.org/10.1016/j.neurobiolaging.2020.08.017)

[Liu J, et al., TET enzymes as therapeutic targets in neurodegeneration (2022)](https://doi.org/10.1016/j.tips.2022.04.005)

[Pietrzykowski A, et al., Epigenetic alterations in Parkinson's disease (2023)](https://doi.org/10.1007/s12035-023-03112-8)

[Sahakian S, et al., TET2-mediated 5hmC alterations in Alzheimer's disease brain (2024)](https://doi.org/10.1007/s00401-024-02611-4)

[McGhee E, et al., Clonal hematopoiesis of indeterminate potential and neurodegeneration (2023)](https://doi.org/10.1038/s41593-023-01234-5)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Epigenetic Memory Erasure via TET2 Activation](/hypothesis/h-d2722680) — <span style="color:#ffd54f;font-weight:600">0.51</span> · Target: TET2
[TET2-Mediated Demethylation Rejuvenation Therapy](/hypothesis/h-d7121bcc) — <span style="color:#ffd54f;font-weight:600">0.46</span> · Target: TET2
[Temporal TET2-Mediated Hydroxymethylation Cycling](/hypothesis/h-a90e2e89) — <span style="color:#ffd54f;font-weight:600">0.40</span> · Target: TET2

Pathway Diagram

The following diagram shows the key molecular relationships involving TET2 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

TET2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tet2
kg_node_id	TET2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-346499007ccc
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tet2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

221

Outgoing

245

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TET2 Gene

TET2 Gene

Overview

TET2 Gene

Overview

Pathway Diagram

Gene Information

Molecular Function

Catalytic Activity

Protein Structure

Role in the Brain

Neuronal Expression and Function

5hmC in Brain Development and Aging

TET2 in Neuroinflammation

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Frontotemporal Dementia

Amyotrophic Lateral Sclerosis (ALS)

Clonal Hematopoiesis and Neurodegeneration

Mechanistic Links

Therapeutic Implications

Small Molecule Activators

Gene Therapy Approaches

Anti-inflammatory Strategies

Expression Patterns

Tissue Distribution

Developmental Regulation

TET2 and the Epigenetic Clock

DNA Methylation Aging

Implications for Neurodegeneration

TET2 in Specific Brain Regions

Hippocampus

Prefrontal Cortex

Substantia Nigra

Cerebellum

TET2 and Protein Aggregation

Amyloid Metabolism

Tau Pathology

Alpha-Synuclein

TET2 and Mitochondrial Function

Mitochondrial DNA Epigenetics

Neurodegeneration Implications

TET2 and Synaptic Function

Synaptic Plasticity

Synaptic Dysfunction in Disease

Animal Models

Mouse Models

Phenotypic Findings

Limitations and Considerations

TET2 in Specific Cell Types

Neurons

Astrocytes

Microglia

Oligodendrocytes

TET2 and Metabolic Disease

Diabetes and Neurodegeneration

Obesity and Brain Aging

TET2 Variants and Mutation Spectrum

Germline Variants

Somatic Mutations

TET2 and Blood-Brain Barrier

BBB Breakdown in Neurodegeneration

Therapeutic Implications

Clinical Trials and Interventions

Current Clinical Landscape

Therapeutic Strategies

Challenges

Research Methods

5hmC Detection

TET2 Activity Assays

Single-Cell Approaches

Cross-Links

Interactions and Pathways

Protein Interactions

Signaling Pathways

Clinical Relevance

Biomarkers

Genetic Testing